Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856654) titled 'Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pain Management' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Aditi Talkad
Condition:
Pelvic Organ Prolapse (POP)
Postoperative Pain
Urogynecology
Intervention:
Drug: Suzetrigine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: November 2026
Target Sample Size: 48
Countries of Recruitment:
United States
To know more, visit h...